Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
Alliance, chemical, CNS, concentration, conclusion, customer, dependent, directly, favorable, Gastroenterology, lab, lower, modification, open, paused, Preclinical, prohibited, Provincial, pursuing, reimburse, reimbursement, suboptimal, unfavorable, valid
Removed:
activity, arising, attack, biological, bladder, brain, cell, colon, derivative, desirable, destroy, distinct, DNA, employ, Etoposide, FDA, Figure, firm, killing, lead, leukemia, lymphoma, markedly, penetrate, pharmacological, Podophyllotoxin, prostate, reference, testicular, unwinding, widely
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view